Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.33
0.150.74%
At close: -
$20.56
0.231.13%
After Hours: 6:49 PM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Genmab Stock Price, Quotes and Forecasts | NASDAQ:GMAB | Benzinga
Explore Genmab stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GMAB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genmab (GMAB) stock?
You can purchase shares of Genmab (NASDAQ:GMAB) through any online brokerage.
Who are Genmab (GMAB) competitors?
Other companies in Genmab’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Genmab (GMAB) stock?
Genmab has a consensus price target of $37.33.
What is the current price for Genmab (GMAB)?
The stock price for Genmab (NASDAQ: GMAB) is $20.56 last updated May 20, 2025 at 6:49 PM EDT.
Does Genmab (GMAB) pay a dividend?
There are no upcoming dividends for Genmab.
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Genmab (GMAB) going to split?
There is no upcoming split for Genmab.
What sector and industry does Genmab (GMAB) operate in?
Genmab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
